Moreover, a clear trend emerged, whereby patients whose tumours had low levels of miR- 708 and high EYA3 had worse three-year relapse-free survival rates [ 98 ].
1
—
—
Moreover, a clear trend emerged, whereby patients whose tumours had low levels of miR- 708 and high EYA3 had worse three-year relapse-free survival rates [ 98 ].